Results 51 to 60 of about 12,305,089 (195)
Emergence of Polymyxin Resistance Driven by a PhoQ Mutation in KPC-2-Producing Klebsiella pneumoniae
Background: The emergence of polymyxin-resistant, carbapenem-resistant Klebsiella pneumoniae (CRKP) presents a critical challenge to clinical management.
Huijuan Song +5 more
doaj +1 more source
Xuedong Jia,1,2 Cuohui Guo,1 Zhao Yin,1,2 Wan Zhang,1,2 Shuzhang Du,1,2 Xiaojian Zhang1,2 1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China; 2The Precision Clinical Pharmacy Key ...
Jia X +5 more
doaj
The site of the neuromuscular block produced by polymyxin B and rolitetracycline
The site of neuromuscular blockade induced by polymyxin B and rolitetracycline was studied on isolated nerve and nerve–muscle preparations. Polymyxin B (1.8 × 10−4 M) was equipotent to lidocaine as a local anaesthetic on a frog desheathed nerve ...
B. Collier, J. M. Wright
core +1 more source
Due to limited new antibiotics, polymyxins are increasingly used to treat multidrug-resistant (MDR) Gram-negative bacteria, in particular carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae.
Thien B. Tran +9 more
doaj +1 more source
Xiaohong Xu,1,* Rongping Zhu,1,* Siyan Lian,1 Hui Zhang,2 Xin Chen,2 Lingfang Fan,1 Peisong Chen,2 Yingping Cao1 1Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, People’s Republic of China; 2Medical ...
Xu X +7 more
doaj
An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics
Objective: To review recent clinical pharmacokinetic and pharmacodynamic data to optimize dosing regimens for polymyxin B and colistin for treatment of infections due to A. baumannii.
Zahra Kassamali +2 more
doaj +1 more source
Polymyxin B interacts with the Psl extracellular matrix.
Images of WT PAO1, PA14, ΔpslAB, PBAD-psl, and CF127 biofilms subjected to 5 µg/ml fluorescent polymyxin B after 2 hours of exposure. Polymyxin B accumulates in the extracellular material of PBAD-psl and is less pronounced in WT PAO1 biofilms ...
Maria Ramirez Millan (443595) +6 more
core +1 more source
Pulmonary Target Delivery of Polymyxin B for Enhanced Efficacy
Objective: Polymyxin B is increasingly used as the last resort for multidrug resistant (MDR) Gram-negative bacterial infections. Limited by high polarity of the drug and poor penetration into the pulmonary epithelial lining fluid (ELF), polymyxin B does ...
He, Jie 1981-
core +1 more source
Pseudomonas aeruginosa (P. aeruginosa) is an aerobic gram-negative, non-spore forming, rod-shaped bacterium. It accelerates the decline in lung function and ultimately leads to increased mortality and morbidity rate.
Muhammad Salman +11 more
doaj +1 more source
Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii [PDF]
Administering polymyxin antibiotics in a traditional fashion may be ineffective against Gram-negative ESKAPE ( Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter ...
Nation, Roger L. +10 more
core +1 more source

